Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Lyon, Gholson J.
  • Vedaie, Marall
  • Beisheim, Travis
  • Park, Agnes
  • Marchi, Elaine
  • Gottlieb, Leah
  • Hsieh, Tzung-Chien
  • Klinkhammer, Hannah
  • Sandomirsky, Katherine
  • Cheng, Hanyin
  • Starr, Lois J.
  • Preddy, Isabelle
  • Tseng, Marcellus
  • Li, Quan
  • Hu, Yu
  • Wang, Kai
  • Carvalho, Ana
  • Gavin, Maureen
  • Amble, Karen
  • Krawitz, Peter
  • Marmorstein, Ronen
  • Herr-Israel, Ellen

Grupos

Abstract

Amino-terminal (Nt-) acetylation (NTA) is a common protein modification, affecting 80% of cytosolic proteins in humans. The human essential gene, NAA10, encodes for the enzyme NAA10, which is the catalytic subunit in the N-terminal acetyltransferase A (NatA) complex, also including the accessory protein, NAA15. The full spectrum of human genetic variation in this pathway is currently unknown. Here we reveal the genetic landscape of variation in NAA10 and NAA15 in humans. Through a genotype-first approach, one clinician interviewed the parents of 56 individuals with NAA10 variants and 19 individuals with NAA15 variants, which were added to all known cases (N=106 for NAA10 and N=66 for NAA15). Although there is clinical overlap between the two syndromes, functional assessment demonstrates that the overall level of functioning for the probands with NAA10 variants is significantly lower than the probands with NAA15 variants. The phenotypic spectrum includes variable levels of intellectual disability, delayed milestones, autism spectrum disorder, craniofacial dysmorphology, cardiac anomalies, seizures, and visual abnormalities (including cortical visual impairment and microphthalmia). One female with the p.Arg83Cys variant and one female with an NAA15 frameshift variant both have microphthalmia. The frameshift variants located toward the C-terminal end of NAA10 have much less impact on overall functioning, whereas the females with the p.Arg83Cys missense in NAA10 have substantial impairment. The overall data are consistent with a phenotypic spectrum for these alleles, involving multiple organ systems, thus revealing the widespread effect of alterations of the NTA pathway in humans.

© 2023. The Author(s).

Datos de la publicación

ISSN/ISSNe:
1018-4813, 1476-5438

EUROPEAN JOURNAL OF HUMAN GENETICS  NATURE PUBLISHING GROUP

Tipo:
Article
Páginas:
824-833
Factor de Impacto:
1,713 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 5

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • N-TERMINAL ACETYLATION; ACETYLTRANSFERASES; IDENTIFICATION; LETHALITY; YEAST; MODEL

Proyectos asociados

RED DE BIOBANCOS (BIOBANCOS)

RD09/0076/00021 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.

Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO

PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

LA RUTA DE LA OXITOCINA EN LOS TRASTORNOS DEL ESPECTRO AUTISTA: IMPORTANCIA DE LAS VARIANTES GENÉTICAS CON RELEVANCIA FUNCIONAL.

Investigador Principal: CARMEN ORELLANA ALONSO

2014_0056_CRC_ORELLANA . 2014

ABORDAJE GENÓMICO PARA LA IDENTIFICACIÓN DE NUEVOS GENES Y MÓDULOS FUNCIONALES RESPONSABLES DE DISCAPACIDAD INTELECTUAL GRAVE.

Investigador Principal: FRANCISCO MARTÍNEZ CASTELLANO

PI14/00350 . INSTITUTO DE SALUD CARLOS III . 2015

NUEVA APROXIMACIÓN GENÓMICA PARA EL DIAGNÓSTICO DE AUTISMO Y DISCAPACIDAD INTELECTUAL: IMPORTANCIA DE LAS MUTACIONES ADQUIRIDAS EN MOSAICISMO SOMÁTICO Y DE NUEVOS GENES CANDIDATOS.

Investigador Principal: SANDRA MONFORT MEMBRADO

2018_0170_CRC_MUTUA MADRILEÑA_MONFORT . FUNDACION MUTUA MADRILEÑA . 2018

Caracterización clínica de los resultados ómicos: reanálisis, nuevos fenotiposaléicos y nuevos genes patológicos.

Investigador Principal: FRANCISCO MARTÍNEZ CASTELLANO

PI22/00272 . INSTITUTO DE SALUD CARLOS III . 2023

Diagnóstico genético de anomalías estructurales fetales mediante secuenciación del genoma completo: rendimiento diagnóstico en contexto prenatal.

Investigador Principal: LAIA PEDROLA VIDAL

PI22/01127 . INSTITUTO DE SALUD CARLOS III . 2023

Cita

Compartir